>Marché européen des diagnostics de santé pour les femmes, par application (tests du cancer du sein, tests du cancer du col de l'utérus, tests de grossesse et de fertilité, tests du cancer de l'ovaire, tests des maladies infectieuses , tests à ultrasons, tests des maladies sexuellement transmissibles et autres), tests (biopsies, autres tests du cancer du sein, tests de grossesse et de fertilité, tests en laboratoire, tests de grossesse et kits de prédiction de l'ovulation, moniteurs de fertilité, dépistage génétique prénatal et tests de porteur, tests de mucoviscidose, tests du syndrome de Down et du syndrome d'Edwards, tests TORCH, autres tests de maladies génétiques prénatales, tests des maladies infectieuses, tests SARM, tests des infections urinaires, tests de l'hépatite) et par utilisateur final (centres de diagnostic et d'imagerie, hôpitaux et cliniques et soins à domicile) - Tendances et prévisions de l'industrie jusqu'en 2029
Analyse et taille du marché
Selon l'Organisation mondiale de la santé, plus de 470 millions de femmes vivent en Europe, ce qui représente un peu plus de la moitié de la population totale. Pour comprendre les changements démographiques et épidémiologiques qui se produisent dans cette région diversifiée, comme le vieillissement et la migration, il faut comprendre la santé des femmes. En outre, le PIB de la région de l'Union européenne s'élevait à environ 18 800 milliards de dollars en 2018, selon la Banque mondiale, et les dépenses de santé constituent le deuxième poste de dépenses publiques après les dépenses de sécurité sociale. Les dépenses totales de santé du gouvernement fédéral s'élevaient à 9,6 % du PIB. Cela augmentera les infrastructures de soins de santé et le nombre de laboratoires cliniques et d'installations de diagnostic en Europe, ce qui stimulera le marché des diagnostics de santé des femmes au cours de l'année à venir.
Data Bridge Market Research estime que le marché du diagnostic de santé des femmes, qui était de 26,48 milliards USD en 2021, devrait grimper à 41,88 milliards USD d'ici 2029 et devrait connaître un TCAC de 5,9 % au cours de la période de prévision 2022-2029. Le rapport de marché élaboré par l'équipe Data Bridge Market Research comprend une analyse approfondie des experts, une épidémiologie des patients, une analyse du pipeline, une analyse des prix et un cadre réglementaire.
Définition du marché
La santé des femmes fait référence au diagnostic et au traitement des maladies qui peuvent affecter le bien-être physique et mental d'une femme. La santé des femmes comprend la contraception, les infections sexuellement transmissibles (IST), les troubles gynécologiques, le cancer du sein, le cancer des ovaires, d'autres cancers féminins, la ménopause, l'hormonothérapie, l'ostéoporose, la grossesse et l'accouchement, la santé sexuelle, les femmes et les maladies cardiaques, ainsi que les affections bénignes affectant le fonctionnement des organes reproducteurs féminins.
Portée du rapport et segmentation du marché
|
Rapport métrique |
Détails |
|
Période de prévision |
2022 à 2029 |
|
Année de base |
2021 |
|
Années historiques |
2020 (personnalisable de 2019 à 2014) |
|
Unités quantitatives |
Chiffre d'affaires en milliards USD, volumes en unités, prix en USD |
|
Segments couverts |
Application (Breast Cancer Testing, Cervical Cancer Testing, Pregnancy and Fertility Testing, Ovarian Cancer Testing, Infectious Disease Testing, Ultrasound Tests, Sexually Transmitted Disease Testing, and Others), and by End-User (Diagnostic and Imaging Centers, Hospitals and Clinics, and Home Care) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe |
|
Market Players Covered |
Siemens (Germany), Hologic, Inc. (MA), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Abbott (U.S.), BD (NJ), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), NeuroLogica Corp.(U.S.A), Shimadzu Medical (India) pvt. Ltd. (Japan), GENERAL ELECTRIC (U.S.), Quest Diagnostics Incorporated (U.S.), Sysmex India Pvt. Ltd. (Japan), Hitachi, Ltd. (Japan), Canon Inc. (Japan), FUJIFILM Holdings Corporation (U.K) |
|
Market Opportunities |
|
Women’s Health Diagnostics Market Dynamics
Drivers
- Increasing incidence of chronic and lifestyle-related disorders
The expanding number of imaging and diagnostic centres, as well as the expanded usage of point-of-care and fast diagnostic tests. As the prevalence of osteoarthritis, ovarian cancer, breast cancer, and cervical cancer rises, the market for women's health diagnostics is growing. Breast cancer is the most frequent cancer in women and the second-most-common cancer in the globe. In 2018, nearly 2 million new cases were reported.
- Increase in the rate of approval of point-of-care diagnostic testing
The market is expected to grow as the number of diagnostic and imaging machines sold around the world rises. However, a surge in demand for the development of miniature diagnostic devices, as well as an increase in healthcare infrastructure and new marketing initiatives by key vendors in emerging countries, are expected to provide market expansion during the forecast period of 2022-2029.
- Increasing prevalence of osteoarthritis, ovarian cancer, breast cancer, and cervical cancer
Breast cancer is the most frequent cancer in women and the second-most-common cancer in the globe. According to Globocan 2020, 2,261,419 new cases of breast cancer will be diagnosed in 2020. The rising number of cases has resulted in increased sales of test kits for home use, which is expected to fuel the market's revenue growth throughout the forecast period. Increased acceptance of point-of-care diagnostic testing and an increase in the number of diagnostic and imaging equipment available globally are expected to drive the market forward.
Opportunities
Breast cancer's rising prevalence, greater research and development spending, and improvements in cancer diagnostics are all expected to accelerate segmental expansion. According to Globocan, roughly 2.26 million new instances of breast cancer were diagnosed in females worldwide in 2020, accounting for around 11.7 percent of all cancer cases. As the patient pool for breast cancer develops, demand for diagnostics is projected to climb even quicker. Product launches are another major factor in the market's expansion.
Restraints/Challenges
Patients' resistance to early screening, which needs considerable expenditures for detection, the possibility of over-diagnosis and overtreatment, and the fact that MRI scans are accurate yet time consuming and costly for patients are all problems that the women's health diagnostic market faces.
Diagnostic tests for women's health are costly, which is a significant barrier to market entry. The women's health diagnostic sector has considerable challenges due to a lack of information about various illnesses and diagnostic methodologies. Low-income companies and emerging economies are addressing market constraints in women's health diagnostics.
This women’s health diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the women’s health diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Women’s Health Diagnostics Market
Due to capital market and global economy uncertainty, limited transit options and travel restrictions created impediments to international trade and transportation during the COVID-19 pandemic, affecting the supply chain for women's health diagnostics and temporarily lowering demand. The advancement of this industry is impeded by unfavourable changes in rules and laws. According to major regulatory organisations, COVID-19 infection is more common in breast cancer patients than in healthy people. Screening, surgical operations, and diagnostic screenings at hospitals and breast cancer clinics have all been postponed or severely curtailed as a result.
Recent Development
- Roche announced in May 2019 that the VENTANA HER2 Dual ISH DNA Probe Cocktail assay for detecting the HER2 biomarker in gastric and breast cancer would be available. This would contribute to the company's product line being expanded.
Europe Women’s Health Diagnostics Market Scope
The women’s health diagnostics market is segmented on the basis of test, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Application
- Osteoporosis Testing
- Bone Densitometry
- In Vitro Blood Tests
- OVC Testing
- OVC Tumor Marker Tests
- OVC Diagnostic Imaging Tests
- Other OVC Tests
- Cervical Cancer Testing
- Pap Smears
- HPV Testing
- Breast Cancer Testing
- Mammography
Tests
- Biopsies
- Other Breast Cancer Tests
- Pregnancy and Fertility Testing
- Lab-based Testing
- Pregnancy Testing and Ovulation Prediction Kits
- Fertility Monitors
- Prenatal Genetic Screening and Carrier Testing
- CF Testing
- Down’s Syndrome and Edwards’ Syndrome Testing
- TORCH Testing
- Other Prenatal Genetic Disease Tests
- Infectious Disease Testing
- MRSA Testing
- UTI Testing
- Hepatitis Testing
- Tuberculosis Testing
- Other Infectious Disease Tests
- STD Testing
- CT/NG Testing
- HIV Testing
- Other STD Tests
- Ultrasound Tests
- Breast Imaging
- OB/GYN Imaging
End-User
- Hospitals and Clinics
- Diagnostic and Imaging Centers
- Home Care Settings
Women’s Health Diagnostics Market Regional Analysis/Insights
The women’s health diagnostics market is analysed and market size insights and trends are provided by country, test, application and end user as referenced above.
The countries covered in the women’s health diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The high prevalence of cancer among women, the rising incidence of lifestyle-related disorders, the high adoption of technologically advanced products, product launches, and government initiatives, the women's health diagnostic market in North America and Europe is expected to grow steadily.
By increasing campaigns on women's health issues and disease awareness, the Asia-Pacific region has improved its healthcare situation and has emerged as a growing participant in the women's health diagnostic market.
La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces de Porter, les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.
Croissance des infrastructures de santé Base installée et pénétration des nouvelles technologies
Le marché du diagnostic de santé des femmes vous fournit également une analyse détaillée du marché pour chaque pays, la croissance des dépenses de santé pour les équipements en capital, la base installée de différents types de produits pour le marché du diagnostic de santé des femmes, l'impact de la technologie à l'aide de courbes de vie et les changements dans les scénarios réglementaires des soins de santé et leur impact sur le marché du diagnostic de santé des femmes. Les données sont disponibles pour la période historique 2010-2020.
Analyse du paysage concurrentiel et des parts de marché du diagnostic de la santé des femmes
Le paysage concurrentiel du marché des diagnostics de santé des femmes fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché des diagnostics de santé des femmes.
Certains des principaux acteurs opérant sur le marché du diagnostic de santé des femmes sont :
- Siemens (Allemagne)
- Hologic, Inc. (Massachusetts)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Chine)
- Abbott (États-Unis)
- BD (New Jersey)
- F. Hoffmann-La Roche SA (Suisse)
- Thermo Fisher Scientific Inc. (États-Unis)
- Koninklijke Philips NV (Pays-Bas)
- NeuroLogica Corp. (États-Unis)
- Shimadzu Medical (Inde) pvt. Ltd. (Japon)
- GENERAL ELECTRIC (ÉTATS-UNIS)
- Quest Diagnostics Incorporated (États-Unis)
- Sysmex Inde Pvt. Ltd. (Japon)
- Hitachi, Ltd. (Japon)
- Canon Inc. (Japon)
- FUJIFILM Holdings Corporation (Royaume-Uni)
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR VENDOR SHARE ANALYSIS
2.8 MULTIVARIATE MODELING
2.9 PRODUCTS LIFELINE CURVE
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 INCREASING GERIATRIC FEMALE POPULATION
3.1.2 INCREASING NUMBER OF INFECTIOUS AND CHRONIC DISEASES
3.1.3 INCREASING INVESTMENTS IN THE RESEARCH AND DEVELOPMENTAL ACTIVITIES
3.1.4 GROWING NUMBER OF DIAGNOSTIC DEVICE MANUFACTURING COMPANIES
3.2 RESTRAINTS
3.2.1 PRODUCT RECALLS OF VARIOUS COMPANIES
3.2.2 HIGH COST OF DIAGNOSTIC PRODUCTS
3.3 OPPORTUNITIES
3.3.1 TECHNOLOGICAL ADVANCEMENTS IN THE DIAGNOSTIC EQUIPMENT
3.3.2 STRATEGIC INITIATIVES BY VARIOUS COMPANIES
3.4 CHALLENGES
3.4.1 UNACCEPTABLE HEALTH DISPARITIES IN THE U.S.
3.4.2 PRICING PRESSURE
3.4.3 INCREASING ADOPTION OF REFURBISHED DIAGNOSTIC IMAGING SYSTEMS
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES
6.1 OVERVIEW
6.2 IMAGING AND MONITORING SYSTEMS
6.2.1 MAMMOGRAPHY SYSTEMS
6.2.1.1 DEVICES
6.2.1.1.1 DIGITAL MAMMOGRAPHY SYSTEMS
6.2.1.1.2 BREAST TOMOSYNTHESIS
6.2.1.1.3 ANALOG MAMMOGRAPHY SYSTEMS
6.2.1.2 APPLICATIONS
6.2.1.2.1 BREAST LUMPS OR TUMORS
6.2.1.2.2 BREAST CANCER
6.2.1.2.3 OTHERS
6.2.2 ULTRASOUND IMAGING SYSTEMS
6.2.2.1 DEVICES
6.2.2.1.1 OB/GYN ULTRASOUND
6.2.2.1.2 BREAST ULTRASOUND
6.2.2.2 APPLICATIONS
6.2.2.2.1 PREGNANCY SCAN
6.2.2.2.1.1 FETAL DEVELOPMENT
6.2.2.2.1.2 FETAL ABNORMALITIES
6.2.2.2.1.3 OTHERS
6.2.2.2.2 PELVIC SCAN
6.2.2.2.2.1 ABNORMAL PERIODS
6.2.2.2.2.2 CYSTS
6.2.2.2.2.3 FIBROIDS
6.2.2.2.2.4 OTHERS
6.2.2.2.3 ABDOMINAL SCAN
6.2.2.2.4 OTHERS
6.2.2.2.4.1 BREAST SCANS
6.2.2.2.4.2 MUSCULOSKELETAL SCANS
6.2.2.2.4.3 INTERNAL STRUCTURES
6.2.3 MRI SYSTEMS
6.2.3.1 APPLICATIONS
6.2.3.1.1 BREAST SCAN
6.2.3.1.2 ABDOMEN SCAN
6.2.3.1.3 JOINTS SCAN
6.2.3.1.4 SPINAL CORD SCAN
6.2.3.1.5 CARDIAC SCAN
6.2.3.1.6 BLOOD VESSELS SCAN
6.2.3.1.7 OTHERS
6.2.4 FERTILITY MONITORS
6.2.4.1 APPLICATIONS
6.2.4.1.1 OVULATION
6.2.4.1.2 INFERTILITY
6.2.4.1.3 PREGNANCY
6.2.4.1.4 HORMONAL IMBALANCE
6.2.4.1.5 OTHERS
6.2.5 BONE DENSITOMETER
6.2.5.1 APPLICATIONS
6.2.5.1.1 OSTEOPOROSIS
6.2.5.1.2 BONE-RELATED PROBLEMS
6.2.5.1.3 RHEUMATOID ARTHRITIS
6.2.6 NUCLEAR IMAGING SYSTEMS
6.2.6.1 APPLICATIONS
6.2.6.1.1 OSTEOARTHRITIS
6.2.6.1.2 HEART DISEASE
6.2.6.1.3 UROLOGICAL PROBLEMS
6.2.6.1.4 GYNECOLOGICAL CANCERS
6.2.6.1.5 MULTIPLE SCLEROSIS
6.2.6.1.6 ALZHEIMER’S DISEASE
6.2.6.1.7 THYROID DISEASE
6.2.6.1.8 SEXUALLY TRANSMITTED INFECTIONS
6.2.6.1.9 STROKE
6.2.6.1.10 POST-TRAUMATIC STRESS DISORDER (PTSD)
6.2.6.1.11 LUPUS
6.2.6.1.12 OTHERS
6.2.7 OTHERS
6.3 BIOPSY DEVICES
6.3.1 BIOPSY FOR CANCER
6.3.1.1 BREAST CANCER
6.3.1.2 CERVICAL CANCER
6.3.1.3 OVARIAN CANCER
6.3.1.4 OTHERS
6.3.2 BREAST LUMPS BIOPSY
6.3.3 BLOOD BIOPSY
6.3.3.1 CANCEROUS
6.3.3.2 NON-CANCEROUS
6.3.4 LYMPH NODES BIOPSY
6.3.5 THYROID BIOPSY
6.3.6 SKIN BIOPSY
6.3.7 OTHERS
6.4 REAGENTS AND KITS
6.4.1 PREGNANCY AND FERTILITY TESTING KITS
6.4.1.1 PREGNANCY
6.4.1.2 OVULATION
6.4.1.3 OTHERS
6.4.2 BLOOD TEST TYPE KIT
6.4.2.1 OSTEOPOROSIS
6.4.2.2 BLOOD CHEMISTRY & BLOOD CELL COUNT
6.4.2.3 OTHERS
6.4.3 HEPATITIS TESTING KIT
6.4.4 TUMOR MARKER ELISA TEST KIT
6.4.5 STD TEST KITS
6.4.5.1 HIV TESTING
6.4.5.2 HUMAN PAPILLOMAVIRUS (HPV) TESTING
6.4.5.3 CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TESTING
6.4.5.4 OTHERS
6.4.6 PAP SMEAR TEST KIT
6.4.7 MRSA TESTING KITS
6.4.8 HORMONE MARKERS ELISA KITS
6.4.9 TUBERCULOSIS TEST KIT
6.4.10 OTHERS
6.5 BIOMARKERS
6.5.1 ONCOLOGY
6.5.1.1 BREAST CANCER
6.5.1.2 CERVICAL CANCER
6.5.1.3 OVARIAN CANCER
6.5.1.4 OTHERS
6.5.2 PREGNANCY COMPLICATIONS
6.5.3 INFECTIOUS DISEASES
6.5.4 CARDIOVASCULAR DISEASES
6.5.5 OTHERS
6.6 OTHERS
7 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY END USER
7.1 OVERVIEW
7.2 HOSPITALS
7.3 DIAGNOSTIC AND IMAGING CENTERS
7.4 CLINICS
7.5 HOME CARE SETTING
8 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY GEOGRAPHY
8.1 EUROPE
8.1.1 GERMANY
8.1.2 FRANCE
8.1.3 U.K.
8.1.4 ITALY
8.1.5 SPAIN
8.1.6 RUSSIA
8.1.7 SWITZERLAND
8.1.8 NETHERLANDS
8.1.9 BELGIUM
8.1.10 TURKEY
8.1.11 REST OF EUROPE
9 EUROPE BIOPSY DEVICES IN WOMEN’S HEALTH DIAGNOSTICS MARKET, COMPANY LANDSCAPE
9.1 COMPANY SHARE ANALYSIS: EUROPE
10 EUROPE MAMMOGRAPHY SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET, COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: EUROPE
11 EUROPE ULTRASONIC IMAGING SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: EUROPE
12 EUROPE MRI SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET, COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: EUROPE
13 COMPANY PROFILE
13.1 HOLOGIC INC
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 COMPANY SHARE ANALYSIS
13.1.4 PRODUCT PORTFOLIO
13.1.5 RECENT DEVELOPMENTS
13.2 SIEMENS
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT DEVELOPMENTS
13.3 GENERAL ELECTRIC
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 PRODUCT PORTFOLIO
13.3.5 RECENT DEVELOPMENT
13.4 KONINKLIJKE PHILIPS N.V.
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 COMPANY SHARE ANALYSIS
13.4.4 PRODUCT PORTFOLIO
13.4.5 RECENT DEVELOPMENTS
13.5 HITACHI, LTD.
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 COMPANY SHARE ANALYSIS
13.5.4 PRODUCT PORTFOLIO
13.5.5 RECENT DEVELOPMENTS
13.6 FUJIFILM HOLDINGS CORPORATION
13.6.1 COMPANY SNAPSHOT
13.6.2 REVENUE ANALYSIS
13.6.3 COMPANY SHARE ANALYSIS
13.6.4 PRODUCT PORTFOLIO
13.6.5 RECENT DEVELOPMENTS
13.7 ABBOTT
13.7.1 COMPANY SNAPSHOT
13.7.2 REVENUE ANALYSIS
13.7.3 PRODUCT PORTFOLIO
13.7.4 RECENT DEVELOPMENTS
13.8 BD
13.8.1 COMPANY SNAPSHOT
13.8.2 REVENUE ANALYSIS
13.8.3 PRODUCT PORTFOLIO
13.8.4 RECENT DEVELOPMENTS
13.9 BIOMERIEUX SA
13.9.1 COMPANY SNAPSHOT
13.9.2 REVENUE ANALYSIS
13.9.3 PRODUCT PORTFOLIO
13.9.4 RECENT DEVELOPMENT
13.1 BIOMERIEUX SA
13.10.1 COMPANY SNAPSHOT
13.10.2 REVENUE ANALYSIS
13.10.3 PRODUCT PORTFOLIO
13.10.4 RECENT DEVELOPMENT
13.11 CANON INC.
13.11.1 COMPANY SNAPSHOT
13.11.2 REVENUE ANALYSIS
13.11.3 PRODUCT PORTFOLIO
13.11.4 RECENT DEVELOPMENTS
13.12 CARDINAL HEALTH
13.12.1 COMPANY SNAPSHOT
13.12.2 REVENUE ANALYSIS
13.12.3 PRODUCT PORTFOLIO
13.12.4 RECENT DEVELOPMENT
13.13 CARESTREAM HEALTH
13.13.1 COMPANY SNAPSHOT
13.13.2 PRODUCT PORTFOLIO
13.13.3 RECENT DEVELOPMENT
13.14 COOK
13.14.1 COMPANY SNAPSHOT
13.14.2 DIVISION PORTFOLIO
13.14.3 RECENT DEVELOPMENTS
13.15 DANAHER
13.15.1 COMPANY SNAPSHOT
13.15.2 REVENUE ANALYSIS
13.15.3 PRODUCT PORTFOLIO
13.15.4 RECENT DEVELOPMENTS
13.16 F. HOFFMANN-LA ROCHE LTD.
13.16.1 COMPANY SNAPSHOT
13.16.2 REVENUE ANALYSIS
13.16.3 PRODUCT PORTFOLIO
13.16.4 RECENT DEVELOPMENTS
13.17 MEDGYN PRODUCTS, INC
13.17.1 COMPANY SNAPSHOT
13.17.2 PRODUCT PORTFOLIO
13.17.3 RECENT DEVELOPMENT
13.18 NEUROLOGICA CORP.
13.18.1 COMPANY SNAPSHOT
13.18.2 PRODUCT PORTFOLIO
13.18.3 RECENT DEVELOPMENTS
13.19 PERKINELMER INC.
13.19.1 COMPANY SNAPSHOT
13.19.2 REVENUE ANALYSIS
13.19.3 PRODUCT PORTFOLIO
13.19.4 RECENT DEVELOPMENT
13.2 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
13.20.1 COMPANY SNAPSHOT
13.20.2 PRODUCT PORTFOLIO
13.20.3 RECENT DEVELOPMENTS
13.21 SHIMADZU CORPORATION
13.21.1 COMPANY SNAPSHOT
13.21.2 REVENUE ANALYSIS
13.21.3 PRODUCT PORTFOLIO
13.21.4 RECENT DEVELOPEMNT
13.22 SYSMEX CORPORATION
13.22.1 COMPANY SNAPSHOT
13.22.2 REVENUE ANALYSIS
13.22.3 PRODUCT PORTFOLIO
13.22.4 RECENT DEVELOPMENT
13.23 THERMO FISHER SCIENTIFIC INC.
13.23.1 COMPANY SNAPSHOT
13.23.2 REVENUE ANALYSIS
13.23.3 PRODUCT PORTFOLIO
13.23.4 RECENT DEVELOPMENTS
13.24 URIT MEDICAL ELECTRONIC CO., LTD
13.24.1 COMPANY SNAPSHOT
13.24.2 PRODUCT PORTFOLIO
13.24.3 RECENT DEVELOPMENT
14 CONCLUSION
15 SWOT ANALYSIS AND DBMR ANALYSIS
15.1 SWOT ANALYSIS
15.2 DATA BRIDGE MARKET RESEARCH ANALYSIS
16 QUESTIONNAIRE
17 RELATED REPORTS
Liste des tableaux
TABLE 1 RESEARCH AND DEVELOPMENT (USD MILLION)
TABLE 2 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 3 EUROPE IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 4 EUROPE IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 5 EUROPE MAMMOGRAPHY SYSTEMS DEVICES IN WOMEN’S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICE, 2017-2026 (USD MILLION)
TABLE 6 EUROPE APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICE , 2017-2026 (USD MILLION)
TABLE 7 EUROPE ULTRASOUND IMAGING SYSTEMS DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICE , 2017-2026 (USD MILLION)
TABLE 8 EUROPE APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICE , 2017-2026 (USD MILLION)
TABLE 9 EUROPE PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY APPLICATIONS, 2017-2026 (USD MILLION)
TABLE 10 EUROPE PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY APPLICATIONS, 2017-2026 (USD MILLION)
TABLE 11 EUROPE OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY APPLICATIONS, 2017-2026 (USD MILLION)
TABLE 12 EUROPE APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)
TABLE 13 EUROPE APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES , 2017-2026 (USD MILLION)
TABLE 14 EUROPE BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)
TABLE 15 EUROPE APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES , 2017-2026 (USD MILLION)
TABLE 16 EUROPE BIOPSY DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 17 EUROPE BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)
TABLE 18 EUROPE BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES , 2017-2026 (USD MILLION)
TABLE 19 EUROPE BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)
TABLE 20 EUROPE REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 21 EUROPE REAGENTS AND KITS IN WOMEN’S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 22 EUROPE PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 23 EUROPE BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 24 EUROPE STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 25 EUROPE BIOMARKERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 26 EUROPE BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)
TABLE 27 EUROPE ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES , 2017-2026 (USD MILLION)
TABLE 28 EUROPE OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 29 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 30 EUROPE HOSPITALS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 31 EUROPE DIAGNOSTIC AND IMAGING CENTERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 32 EUROPE CLINICS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 33 EUROPE HOME CARE SETTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 34 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 35 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 36 EUROPE IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 37 EUROPE MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 38 EUROPE APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 39 EUROPE ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 40 EUROPE APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 41 EUROPE PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 42 EUROPE PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 43 EUROPE OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 44 EUROPE APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 45 EUROPE APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 46 EUROPE APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 47 EUROPE BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 48 EUROPE BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 49 EUROPE BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 50 EUROPE BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 51 EUROPE BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 52 EUROPE ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 53 EUROPE REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 54 EUROPE PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 55 EUROPE BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 56 EUROPE STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 57 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 58 GERMANY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 59 GERMANY IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 60 GERMANY MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 61 GERMANY APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 62 GERMANY ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 63 GERMANY APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 64 GERMANY PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 65 GERMANY PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 66 GERMANY OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 67 GERMANY APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 68 GERMANY APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 69 GERMANY APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 70 GERMANY BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 71 GERMANY BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 72 GERMANY BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 73 GERMANY BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 74 GERMANY BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 75 GERMANY ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 76 GERMANY REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 77 GERMANY PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 78 GERMANY BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 79 GERMANY STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 80 GERMANY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 81 FRANCE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 82 FRANCE IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 83 FRANCE MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 84 FRANCE APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 85 FRANCE ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 86 FRANCE APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 87 FRANCE PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 88 FRANCE PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 89 FRANCE OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 90 FRANCE APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 91 FRANCE APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 92 FRANCE APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 93 FRANCE BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 94 FRANCE BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 95 FRANCE BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 96 FRANCE BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 97 FRANCE BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 98 FRANCE ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 99 FRANCE REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 100 FRANCE PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 101 FRANCE BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 102 FRANCE STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 103 FRANCE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 104 U.K. WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 105 U.K. IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 106 U.K. MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 107 U.K. APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 108 U.K. ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 109 U.K. APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 110 U.K. PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 111 U.K. PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 112 U.K. OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 113 U.K. APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 114 U.K. APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 115 U.K. APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 116 U.K. BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 117 U.K. BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 118 U.K. BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 119 U.K. BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 120 U.K. BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 121 U.K. ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 122 U.K. REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 123 U.K. PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 124 U.K. BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 125 U.K. STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 126 U.K. WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 127 ITALY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 128 ITALY IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 129 ITALY MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 130 ITALY APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 131 ITALY ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 132 ITALY APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 133 ITALY PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 134 ITALY PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 135 ITALY OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 136 ITALY APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 137 ITALY APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 138 ITALY APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 139 ITALY BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 140 ITALY BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 141 ITALY BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 142 ITALY BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 143 ITALY BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 144 ITALY ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 145 ITALY REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 146 ITALY PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 147 ITALY BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 148 ITALY STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 149 ITALY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 150 SPAIN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 151 SPAIN IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 152 SPAIN MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 153 SPAIN APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 154 SPAIN ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 155 SPAIN APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 156 SPAIN PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 157 SPAIN PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 158 SPAIN OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 159 SPAIN APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 160 SPAIN APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 161 SPAIN APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 162 SPAIN BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 163 SPAIN BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 164 SPAIN BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 165 SPAIN BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 166 SPAIN BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 167 SPAIN ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 168 SPAIN REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 169 SPAIN PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 170 SPAIN BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 171 SPAIN STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 172 SPAIN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 173 RUSSIA WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 174 RUSSIA IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 175 RUSSIA MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 176 RUSSIA APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 177 RUSSIA ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 178 RUSSIA APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 179 RUSSIA PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 180 RUSSIA PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 181 RUSSIA OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 182 RUSSIA APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 183 RUSSIA APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 184 RUSSIA APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 185 RUSSIA BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 186 RUSSIA BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 187 RUSSIA BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 188 RUSSIA BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 189 RUSSIA BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 190 RUSSIA ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 191 RUSSIA REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 192 RUSSIA PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 193 RUSSIA BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 194 RUSSIA STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 195 RUSSIA WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 196 SWITZERLAND WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 197 SWITZERLAND IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 198 SWITZERLAND MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 199 SWITZERLAND APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 200 SWITZERLAND ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 201 SWITZERLAND APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 202 SWITZERLAND PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 203 SWITZERLAND PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 204 SWITZERLAND OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 205 SWITZERLAND APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 206 SWITZERLAND APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 207 SWITZERLAND APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 208 SWITZERLAND BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 209 SWITZERLAND BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 210 SWITZERLAND BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 211 SWITZERLAND BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 212 SWITZERLAND BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 213 SWITZERLAND ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 214 SWITZERLAND REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 215 SWITZERLAND PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 216 SWITZERLAND BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 217 SWITZERLAND STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 218 SWITZERLAND WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 219 NETHERLANDS WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 220 NETHERLANDS IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 221 NETHERLANDS MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 222 NETHERLANDS APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 223 NETHERLANDS ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 224 NETHERLANDS APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 225 NETHERLANDS PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 226 NETHERLANDS PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 227 NETHERLANDS OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 228 NETHERLANDS APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 229 NETHERLANDS APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 230 NETHERLANDS APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 231 NETHERLANDS BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 232 NETHERLANDS BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 233 NETHERLANDS BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 234 NETHERLANDS BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 235 NETHERLANDS BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 236 NETHERLANDS ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 237 NETHERLANDS REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 238 NETHERLANDS PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 239 NETHERLANDS BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 240 NETHERLANDS STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 241 NETHERLANDS WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 242 BELGIUM WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 243 BELGIUM IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 244 BELGIUM MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 245 BELGIUM APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 246 BELGIUM ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 247 BELGIUM APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 248 BELGIUM PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 249 BELGIUM PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 250 BELGIUM OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 251 BELGIUM APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 252 BELGIUM APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 253 BELGIUM APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 254 BELGIUM BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 255 BELGIUM BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 256 BELGIUM BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 257 BELGIUM BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 258 BELGIUM BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 259 BELGIUM ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 260 BELGIUM REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 261 BELGIUM PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 262 BELGIUM BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 263 BELGIUM STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 264 BELGIUM WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION
TABLE 265 TURKEY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 266 TURKEY IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 267 TURKEY MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 268 TURKEY APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 269 TURKEY ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 270 TURKEY APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 271 TURKEY PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 272 TURKEY PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 273 TURKEY OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 274 TURKEY APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 275 TURKEY APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 276 TURKEY APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 277 TURKEY BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 278 TURKEY BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 279 TURKEY BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 280 TURKEY BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 281 TURKEY BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)\
TABLE 282 TURKEY ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 283 TURKEY REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 284 TURKEY PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 285 TURKEY BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 286 TURKEY STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
TABLE 287 TURKEY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 288 REST OF EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)
Liste des figures
FIGURE 1 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 2 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: DATA VALIDATION MODEL
FIGURE 3 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: DROC ANALYSIS
FIGURE 4 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: EUROPE VS REGIONAL ANALYSIS
FIGURE 5 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE BIOPSY DEVICES IN WOMEN’S HEALTH DIAGNOSTICS MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 8 EUROPE MAMMOGRAPHY SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 9 EUROPE ULTRASONIC IMAGING SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE MRI SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET
FIGURE 12 PERCENT DISTRIBUTION OF THE 10 LEADING CAUSES OF DEATH IN WOMEN: UNITED STATES, 2017
FIGURE 13 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 14 INCREASING NUMBER OF INFECTIOUS AND CHRONIC DISEASES AND INCREASING INVESTMENTS IN THE RESEARCH AND DEVELOPMENTAL ACTIVITIES ARE EXPECTED TO DRIVE THE EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 15 IMAGING AND MONTORING IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 16 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: BY DIAGNOSTIC DEVICES, 2018
FIGURE 17 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: BY END USER, 2018
FIGURE 18 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: SNAPSHOT (2018)
FIGURE 19 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: BY COUNTRY (2018)
FIGURE 20 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: BY COUNTRY (2019 & 2026)
FIGURE 21 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: BY COUNTRY (2018 & 2026)
FIGURE 22 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: BY DIAGNOSTIC DEVICES (2019-2026)
FIGURE 23 EUROPE BIOPSY DEVISE IN WOMEN’S HEALTH DIAGNOSTICS MARKET: COMPANY SHARE 2018 (%)
FIGURE 24 EUROPE MAMMOGRAPHY SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET: COMPANY SHARE 2018 (%)
FIGURE 25 EUROPE ULTRASONIC IMAGING SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET: COMPANY SHARE 2018 (%)
FIGURE 26 EUROPE MRI SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET: COMPANY SHARE 2018 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
